back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-01-08 18:14 Tx date 2025-01-06 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+757,446 vol |
2,617,410 | |
| Filed 2025-01-08 18:13 Tx date 2025-01-06 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+1,250,000 vol |
1,360,000 | |
| Filed 2025-01-08 18:12 Tx date 2025-01-06 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$25,000
+1,250,000 vol $0.02 each |
1,385,000 | |
| Filed 2023-09-29 17:38 Tx date 2023-09-22 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-1,051,249 vol |
1,859,964 | |
| Filed 2022-10-28 17:51 Tx date 2022-10-27 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$900.00
+5,000 vol $0.18 each |
135,000 | |
| Filed 2022-10-21 17:27 Tx date 2022-10-21 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$330.00
+1,500 vol $0.22 each |
130,000 | |
| Filed 2022-10-19 18:25 Tx date 2022-10-19 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,000
+5,000 vol $0.20 each |
128,500 | |
| Filed 2022-10-05 12:09 Tx date 2022-10-03 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,200
+5,000 vol $0.24 each |
123,500 | |
| Filed 2022-09-09 17:07 Tx date 2022-09-09 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$110.00
+500 vol $0.22 each |
118,500 | |
| Filed 2022-09-09 17:07 Tx date 2022-09-08 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$330.00
+1,500 vol $0.22 each |
118,000 | |
| Filed 2022-08-29 16:39 Tx date 2022-08-26 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$650.00
+2,500 vol $0.26 each |
115,000 | |
| Filed 2022-08-29 16:39 Tx date 2022-08-26 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$550.00
+2,500 vol $0.22 each |
112,500 | |
| Filed 2022-08-29 16:38 Tx date 2022-08-26 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$375.00
+1,500 vol $0.25 each |
116,500 | |
| Filed 2022-08-29 16:37 Tx date 2022-08-26 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$400.00
+2,500 vol $0.16 each |
||
| Filed 2022-08-29 16:37 Tx date 2022-08-26 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$300.00
+2,500 vol $0.12 each |
||
| Filed 2022-03-29 12:28 Tx date 2022-03-29 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$79,200
+110,000 vol $0.72 each |
110,000 | |
| Filed 2022-03-29 12:27 Tx date 2022-03-21 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-03-29 12:26 Tx date 2022-03-29 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$66,000
+110,000 vol $0.60 each |
110,000 | |
| Filed 2022-03-29 11:37 Tx date 2022-03-21 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-09-24 14:26 Tx date 2021-09-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$888.00
+300 vol $2.96 each |
21,228 |